Literature DB >> 22876457

Relationship between urinary nephrin and urinary albumin changes in diabetic rats and effects of yiqiyangyinhuayutongluo recipe.

Li-li Li1, Zhi-qiang Chen, Yue-hua Wang, Jiang-hua Zhang, Zhi-wei Yin, Lin-lin Li, Xue-yun Zhang, Feng-li Wang.   

Abstract

OBJECTIVE: To investigate the dynamic changes of urinary nephrin, and the relationship between it and urinary albumin excretion rate (UAER) in a diabetic rat model, as well the effects of yiqiyangyinhuayutongluo recipe.
METHODS: Diabetic model was induced by high fat diet combined with low-dose Streptozotocin (STZ) in rats. Normal group (NG), model group (MG), and yiqiyangyinhuayutongluo recipe treated group (YHTG) were set. Gastrointestinal Yiqiyangyi-nhuayutongluo recipe was administered once daily for 32 w. At the end of the 2nd w (2 w), 8 w, 16 w, and 32 w, fasting blood glucose (FBG), UAER and 24h urinary nephrin (U-nephrin) were detected.
RESULTS: Compared with NG, FBG in MG increased notably (P < 0.05). Compared with MG, FBG of YHTG (P < 0.05) since 16 w. U-nephrin and UAER in MG increased significantly from 2 w, peaked at 16 w, lessened in different degree at 32 w, but were still higher than NG. The correlation analysis showed that there was a significant positive correlation between U-nephrin and UAER at different time, the correlation coefficient as r > 0.9, and P < 0.05. Compared with MG, U-nephrin and UAER in YHTG decreased markedly (P < 0.05) except for U-nephrin at 8 w.
CONCLUSIONS: U-nephrin and UAER in diabetic rat model have a positive linear correlation. Yiqiyangyinhuayutongluo recipe can reduce UAER markedly, and preventing the lose of nephrin in urine maybe one of the mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22876457     DOI: 10.1016/s0254-6272(13)60025-4

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  5 in total

1.  Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.

Authors:  Yusuke Wada; Masaki Abe; Hiroshi Moritani; Hikaru Mitori; Mitsuhiro Kondo; Keiko Tanaka-Amino; Megumi Eguchi; Akira Imasato; Yutaka Inoki; Hiroshi Kajiyama; Toshihide Mimura; Yuichi Tomura
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-22

2.  Chinese medicines in the treatment of experimental diabetic nephropathy.

Authors:  Jing-Yi Liu; Xiao-Xin Chen; Sydney Chi-Wai Tang; Stephen Cho-Wing Sze; Yi-Bin Feng; Kai-Fai Lee; Kalin Yan-Bo Zhang
Journal:  Chin Med       Date:  2016-02-24       Impact factor: 5.455

3.  The Level of Serum and Urinary Nephrin in Normal Pregnancy and Pregnancy with Subsequent Preeclampsia.

Authors:  Yun Ji Jung; Hee Young Cho; Sihyun Cho; Young Han Kim; Jin Dong Jeon; Young Jin Kim; Sanghoo Lee; Jimyeong Park; Ha Yan Kim; Yong Won Park; Ja Young Kwon
Journal:  Yonsei Med J       Date:  2017-03       Impact factor: 2.759

4.  Balancing the Risk-Benefit Ratio of Immune Checkpoint Inhibitor and Anti-VEGF Combination Therapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Li Tao; Huiyun Zhang; Guangyu An; Haoning Lan; Yaoqi Xu; Yang Ge; Jiannan Yao
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

5.  RUMA and RUPCR in children with Henoch-Schonlein purpura.

Authors:  Xiucui Han; Pengfei Xu
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 3.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.